GenomSys logo — Accelerating Personal Genomics.
GenomSys MPEG-G Genomic Plat...

GenomSys

Accelerating Personal Genomics. GenomSys MPEG-G Genomic Platform enabling genomic 2.0 applications.

Founded 2016 Switzerland Morges, Switzerland 3 employees Series A Total: $9.37M

General Information

Company Name GenomSys
Founded Year 2016
Location Switzerland Morges, Switzerland +2
Founders / Decision Makers
Team member
Employees 3
Funding Stage Series A
Social

Get notified when GenomSys moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GenomSys

GenomSys is a Swiss health software company founded in 2016 with the slogan "Accelerating Personal Genomics." The company's GenomSys MPEG-G Genomic Platform aims to enable genomic 2.0 applications by providing an open standard platform that facilitates scalable and secure personalized genomics. Their unique multi-infrastructure genomic platform, based on the ISO/IEC 23092 genomic standard (MPEG-G), enables fast time-to-market for innovative applications, with cost-effectiveness (storage needs -70%), faster processing (4-month time-to-market of innovative application), and interoperability. Moreover, being an ISO-13485-certified manufacturer of software for medical devices, GenomSys is regulatory conscious and ready for mobile genomics. The company received its last investment of Fr.9.30M in a Series A investment at 16 September 2019. The investors included Dolby Ventures, Club degli Investitori, Elysian Capital LLP, Pygar family offices, Preon Capital Partners, and Susman Ventures. GenomSys is well-positioned to address the increasing demand for data and process efficiency, interoperability, and software robustness in the evolving landscape of genomic applications.

Taxonomy: Personal Genomics, Genomic Platform, MPEG-G, Genomic Data Processing, Bioinformatics, Next-Generation Sequencing, ISO 13485, Interoperability, Data Efficiency, Genetic Analysis Software, Mobile Genomics, ISO/IEC 23092

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 6
Investor Investor Investor
•••• ••••
16 Sep 2019
Grant •••••• 2 •••• •••• 01 Jul 2018
Seed Round •••••• 1 •••• •••• 01 Oct 2016

GenomSys Alternatives & Competitors

GenomSys vs
Fabric Genomics
Fabric Genomics United States

AI‑Driven Clinical Insights for Genomic Data

Series Unknown
27 employees
AI, Biotechnology
GenomSys vs
GENEO
GENEO Turkey

Offering advanced bioinformatics solutions based on genomic data in English.

Analytics, Biotechnology
GenomSys vs

Pioneering the integration of human disease into pharmaceutical discovery, advancing biomedical rese...

Series C
Biotechnology, Health Care

FAQ About GenomSys

Accelerating Personal Genomics. GenomSys MPEG-G Genomic Platform enabling genomic 2.0 applications.
GenomSys was founded in 2016.
GenomSys is headquartered in Morges, Switzerland.
GenomSys has approximately 3 employees.
GenomSys has completed 3 funding rounds, raising a total of $9.37M. The latest funding stage is Series A.
Top alternatives and competitors to GenomSys include Fabric Genomics, GENEO, Ardais Corporation, PhenoTips, Genomenon, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GenomSys and Fabric Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GenomSys and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy